Quidelortho Corpoation ($QDEL) Stock Forecast: Down 5.7% Today

What is Quidelortho Corpoation?

QuidelOrtho (QDEL) is a corporation specializing in diagnostic healthcare solutions. Today, the stock experienced a strong bearish movement in the market.

Why is Quidelortho Corpoation going down?

QDEL stock is down 5.7% on Jun 17, 2026 18:10

• Shareholders approved all management proposals at the Annual Meeting, indicating confidence in the company's direction. However, the stock still saw a bearish trend.
• The high implied volatility in the options market for QDEL stock suggests investors anticipate a significant price movement, possibly contributing to the bearish movement.
• Analysts rating QuidelOrtho as a "Strong Sell" with downward revisions in earnings estimates might have influenced investor sentiment, leading to the bearish market movement.
• The divergence between market sentiment and fundamental analysis, as highlighted by the options market and analyst ratings, could have added to the downward pressure on QDEL stock.

QDEL Price Chart

QDEL Technical Analysis

QDEL News

QuidelOrtho (QDEL) shareholders approve board slate, say-on-pay and KPMG

QuidelOrtho Corporation (QDEL) shareholders approved all management proposals at their 2026 Annual Meeting. This included the election of all ten director nominees, advisory approval of the compensation for named executive officers, and the ratification of KPMG LLP as the independent registered public accounting firm for the 2026 fiscal year. All proposals garnered strong support from stockholders.

https://www.stocktitan.net/sec-filings/QDEL/8-k-quidel-ortho-corp-reports-material-event-5c824fc20694.html

Is the Options Market Predicting a Spike in QuidelOrtho Stock?

The options market is showing high implied volatility for QuidelOrtho (QDEL) stock, specifically for the June 18, 2026 $37.50 Call, suggesting investors anticipate a significant price movement. Despite this, analysts currently rate QuidelOrtho as a "Strong Sell" with downward revisions in earnings estimates, indicating a potential divergence between market sentiment and fundamental analysis. Options traders might use this high implied volatility to sell premiums, banking on the stock not moving as much as expected.

https://www.tradingview.com/news/zacks:485a6da3b094b:0-is-the-options-market-predicting-a-spike-in-quidelortho-stock/

Trending Today

Adobe Inc. ($ADBE) Stock Forecast: Down 5.4% Today

Upwork Inc. ($UPWK) Stock Forecast: Down 5.2% Today

CarMax Inc ($KMX) Stock Forecast: Down 9.9% Today

Gap Inc. ($GAP) Stock Forecast: Down 3.6% Today

Alexandria Real Estate Equities Inc. ($ARE) Stock Forecast: Down 5.4% Today

Baxter International Inc. ($BAX) Stock Forecast: Down 5.1% Today

Franklin Resources Inc. ($BEN) Stock Forecast: Up 0.4% Today

Moderna Inc. ($MRNA) Stock Forecast: Up 10.8% Today

Robinhood Inc. ($HOOD) Stock Forecast: Up 9.4% Today

Meta Platforms, Inc. ($META) Stock Forecast: Down 5.2% Today

Quidelortho Corpoation Price History

15.04.2026 - QDEL Stock was down 5.6%

• The price target for QDEL dropped by 34.46% to $19.25, potentially influencing the bearish trend and reflecting doubts about the company's future performance.
• Despite a 3.0% increase in shares, trading below the GF Value™ of $37.22 suggests possible undervaluation. However, with a low Financial Strength score of 3/10, investors may be worried, leading to selling pressure.
• Positive perceptions of QDEL's stability and growth may have been overshadowed by concerns about missed free cash flow guidance and potential EBITDA impacts from Chinese policy changes, resulting in a cautious stance among traders and investors.
• The combination of a reduced price target, mixed valuation signals, and short-term financial challenges likely played a role in QDEL's recent bearish market movement.

10.05.2026 - QDEL Stock was down 5.2%

• The decline in QDEL's stock price may be linked to regular equity compensation activities by the company's directors. This could have raised concerns among investors about the company's financial stability.
• Despite the positive aspects of their focus on prenatal care and collaboration with the Allo Hope Foundation, market confidence in QDEL's stock did not immediately improve, contributing to the bearish trend.
• Investors are likely keeping a close eye on how the partnership could impact QDEL's financial performance, leading to a cautious stance towards the stock and influencing its downward trajectory.
• In summary, routine equity transactions by directors and recent partnership news, although positive, may have played a role in the negative sentiment surrounding QDEL's stock today.

09.05.2026 - QDEL Stock was down 5.7%

• QDEL stock saw significant bearish movement today.
• The decline in QDEL's stock price is connected to mixed Wall Street price target adjustments subsequent to its Q4 earnings report, which revealed a notable drop in the company's projected free cash flow for 2026 below initial estimates.
• Despite a recent 31% rise in share price, analysts advise caution on the stock's future performance, highlighting the importance of carefully weighing rewards and risks when considering investments.
• The collaboration between QuidelOrtho and the Allo Hope Foundation aimed at enhancing prenatal care for maternal alloimmunization could boost the company's reputation and growth outlook, though this may not have fully countered the negative market sentiment triggered by the earnings report.

03.05.2026 - QDEL Stock was up 5.0%

• QuidelOrtho's collaboration with Allo Hope Foundation to address HDFN in pregnancy indicates the company's commitment to enhancing healthcare outcomes and expanding its presence in critical areas.
• The director at QuidelOrtho receiving shares from RSU release demonstrates confidence in the company's future prospects, potentially contributing to the positive sentiment surrounding QDEL.
• The emphasis on education, early testing, and strategic partnerships align with current market preferences for companies that prioritize innovation and collaboration to tackle significant healthcare challenges.
• Overall, these positive developments likely fueled investor confidence and led to the uptrend in QDEL's stock price today.

03.05.2026 - QDEL Stock was up 10.7%

• QDEL's stock saw a bullish trend possibly due to the partnership announcement with the Allo Hope Foundation to boost education, connection, and early testing for alloimmunized pregnancies.
• The increase in shares acquired by various directors through RSU vesting might have boosted investor confidence and demonstrated faith in the company's growth trajectory.
• Collaborative efforts to improve prenatal care and address hemolytic disease of the fetus and newborn (HDFN) likely fueled investor enthusiasm about QDEL's potential advancements in the healthcare sector.

19.04.2026 - QDEL Stock was up 6.8%

• Despite a decrease in the price target by 34.46% to $19.25, QDEL experienced a strong bullish movement.
• The increase in short interest and cautious analyst sentiment may have initially contributed to bearish pressure on the stock.
• The miss on Q1 earnings estimates and declining revenues could have initially dampened investor confidence.
• The unexpected bullish movement in QDEL could be attributed to potential positive developments within the company, such as new product launches or strategic partnerships, leading investors to reassess the stock's value despite the negative news.

04.05.2026 - QDEL Stock was up 13.0%

• The positive sentiment surrounding QDEL's recent stock performance could be linked to company directors increasing their holdings through the vesting of restricted stock units (RSUs), signaling confidence in the company's future.
• Despite potential near-term risks related to its heavy reliance on respiratory testing, there appears to be optimism in the market regarding QDEL's ability to overcome challenges and seize future opportunities.
• The company's consistent market share, alongside regular compensation activities involving its directors, likely reassured investors about QDEL's growth potential, contributing to today's bullish market trend.

04.05.2026 - QDEL Stock was up 10.8%

• QuidelOrtho's stock surged by 24.1% since its last earnings report, despite reporting a decline in first-quarter 2026 revenue and adjusted loss per share. The revenue did surpass expectations, but analyst estimates have trended downward, resulting in a Zacks Rank #5 (Strong Sell).
• The company faces near-term risks due to its heavy reliance on respiratory testing, which was impacted by a milder respiratory season, leading to reduced demand and financial performance. This sensitivity to respiratory demand fluctuations sets it apart from more diversified competitors like Abbott Laboratories and Thermo Fisher Scientific.
• The positive sentiment from QuidelOrtho directors acquiring shares through RSU vesting may have contributed to the bullish movement, indicating confidence in the company's future prospects despite the challenges it currently faces.
• Overall, the market movement could be a result of a combination of better-than-expected revenue performance, director confidence through share acquisitions, and potential market optimism regarding the company's ability to navigate through its current challenges in the respiratory testing segment.

05.05.2026 - QDEL Stock was down 6.1%

• QuidelOrtho (QDEL) stock faced notable bearish trends, likely influenced by:
• Disappointing first-quarter 2026 financial results showing lower revenues and adjusted loss per share compared to the previous year.
• Decreased demand due to its high reliance on respiratory testing, impacting financial results.
• Analyst estimates pointing towards a negative trend, resulting in a Zacks Rank #5 (Strong Sell).
• The release of restricted stock units (RSUs) by company directors might have also played a role in the negative market sentiment towards the stock, suggesting internal concerns or uncertainty about the company's future performance.

17.05.2026 - QDEL Stock was down 5.7%

• Shareholders approved all management proposals at the Annual Meeting, indicating confidence in the company's direction. However, the stock still saw a bearish trend.
• The high implied volatility in the options market for QDEL stock suggests investors anticipate a significant price movement, possibly contributing to the bearish movement.
• Analysts rating QuidelOrtho as a "Strong Sell" with downward revisions in earnings estimates might have influenced investor sentiment, leading to the bearish market movement.
• The divergence between market sentiment and fundamental analysis, as highlighted by the options market and analyst ratings, could have added to the downward pressure on QDEL stock.

28.04.2026 - QDEL Stock was up 6.6%

• QuidelOrtho Corp (QDEL) stock saw a bullish trend despite being deemed undervalued by GF Value™, signaling a positive outlook from investors.
• The recent launch of episode 58 of a podcast by QuidelOrtho Corporation, which focused on hemolytic disease of the fetus and newborn (HDFN), likely boosted awareness about the company's diagnostic capabilities and solutions, contributing to the optimistic market sentiment.
• Investor confidence may have been bolstered by the discussions on prompt diagnostics and coordinated care for HDFN, showcasing QuidelOrtho Corp's expertise and potential for enhanced results. This led to increased investor interest and the upward movement of the stock.

12.05.2026 - QDEL Stock was up 7.6%

• The increase in QDEL's stock price could be linked to the upbeat sentiment following company directors raising their stakes by releasing and converting restricted stock units (RSUs), indicating a strong vote of confidence in the company's future.
• Director activities involving equity compensation, like exchanging RSUs for common stock, might have signaled to investors that the management is optimistic about QuidelOrtho's long-term growth prospects.
• Positive updates on QDEL, including leadership changes and industry insights, could have contributed to the optimistic momentum, with investors showing confidence in the company's healthcare sector positioning amid ongoing developments related to COVID-19.